RNA-based therapeutics are transforming medicine, but scaling production efficiently remains a challenge, particularly the ...

A presentation by scientists on a work group for the Centers for Disease Control and Prevention’s vaccine advisory panel ...

There's a new frontier in treating autoimmune diseases. Today's treatments tamp down the friendly fire but don't fix what's ...

Mursla Bio, a leader in Extracellular Vesicle (EV) science on a mission to advance precision diagnostics and significantly improve chronic disease outcomes for at-risk patients, today announced a ...

Mursla Bio has announced a new collaboration with a leading global pharmaceutical company to support biomarker-guided drug ...

The 9 therapeutics stocks we track reported a mixed Q3. As a group, revenues beat analysts’ consensus estimates by 5.7%. In ...

New Volume Expands Global Reach of Independent Science as Public Demand Grows for Transparency in Health Research WASHINGTON, Nov. 12, 2025 /PRNewswire/ -- The Independent Medical Alliance (IMA) today ...

Studies including a randomized clinical trial from 1976 found monitoring did not reduce the number of deaths among newborns, ...

AML is a devastating blood cancer with low survival rates, particularly for older patients who cannot tolerate aggressive chemotherapy. Flashpoint's approach offers the potential for a new precision ...